Cargando…
Response and recurrence correlates in individuals treated with neoadjuvant anti-PD-1 therapy for resectable oral cavity squamous cell carcinoma
Neoadjuvant PD-1 blockade may be efficacious in some individuals with high-risk, resectable oral cavity head and neck cancer. To explore correlates of response patterns to neoadjuvant nivolumab treatment and post-surgical recurrences, we analyzed longitudinal tumor and blood samples in a cohort of 1...
Autores principales: | Liu, Sixue, Knochelmann, Hannah M., Lomeli, Shirley H., Hong, Aayoung, Richardson, Mary, Yang, Zhentao, Lim, Raymond J., Wang, Yan, Dumitras, Camelia, Krysan, Kostyantyn, Timmers, Cynthia, Romeo, Martin J., Krieg, Carsten, O’Quinn, Elizabeth C., Horton, Joshua D., Dubinett, Steve M., Paulos, Chrystal M., Neskey, David M., Lo, Roger S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8561238/ https://www.ncbi.nlm.nih.gov/pubmed/34755131 http://dx.doi.org/10.1016/j.xcrm.2021.100411 |
Ejemplares similares
-
Neoadjuvant presurgical PD-1 inhibition in oral cavity squamous cell carcinoma
por: Knochelmann, Hannah M., et al.
Publicado: (2021) -
Immunological effects of nivolumab immunotherapy in patients with oral cavity squamous cell carcinoma
por: Xiong, Ying, et al.
Publicado: (2020) -
Multi-organ landscape of therapy-resistant melanoma
por: Liu, Sixue, et al.
Publicado: (2023) -
Modeling ex vivo tumor-infiltrating lymphocyte expansion from established solid malignancies
por: Knochelmann, Hannah M, et al.
Publicado: (2021) -
Blocking Genomic Instability Prevents Acquired Resistance to MAPK Inhibitor Therapy in Melanoma
por: Dharanipragada, Prashanthi, et al.
Publicado: (2023)